Sabitlenmiş Tweet
My dream is to love what I do so much that I have trouble leaving it 67 years later #ThankYouVin 💙 twitter.com/dodgers/status…
Los Angeles Dodgers@Dodgers
One final time. #ThankYouVin
English
Pauline Funchain
8K posts
Pauline Funchain
@FunchainMD
Melanoma oncology. Study hereditary genetics and irAE. LA explant in SF via OH. Sports fan, geek, and mommy. COI https://t.co/UJ7zV936DV 🦋@funchainmd.bsky.social
Stanford, CA Katılım Ağustos 2016
1.3K Takip Edilen2.5K Takipçiler
One of the wonderful things about doing science @StanfordCancer is incredible support through multiple shared resources supported by SCI. Today we highlight the new Organoid Core led by Claudia Petrisch and Cancer Data Science Core led by @summerhanlab #SCIResearch26
English
Great lesson on data science algorithms by @tmboussard : when a predictive algorithm works @StanfordCancer but fails when at @MassGenBrigham because one hospital uses "Depends" to refer to an adult diaper and the other uses "depends" only as a verb... #SCIresearch26 #LLMproblems
GIF
English
Pauline Funchain retweetledi
Join us for our upcoming webinar!
📅 March 27, 2026 | 3 PM CST
@ASPIRE_CoP
Supported by our community: @FunchainMD, @KMittalMD, @afreenshariffmd, @BryanSchne90417, @EladSharonMD, @mhadfield30, @lexmeara
Scan the QR code below or join via the link in the replies. 👇
English
Good day Bay Area 🌞 Started the morning with a tribute to one of the great motive forces behind @StanfordCancer in late SVP and President Sri Seshadri. Today at #SCIResearch26 has felt like a tribute to the foundation he built for today and tomorrow’s cancer science 🧑🔬🫡
English
Pauline Funchain retweetledi
Successful first day of clinic @StanfordCancer for @JulveMax!! #melanoma #TIL #solidtumorcelltherapy
English
Good afternoon Vancouver 🌞🏔️ It’s 2026 and melanoma data continue to move in TIL 🏋️♀️ @DrBetofMDPhD @StanfordCancer discusses 10 year melanoma survival data for patients who have experienced complete response with earlier versions of TIL #MovingTheGoalPosts #CMC26
English
Pauline Funchain retweetledi
Stanford names leader for drug development & precision oncology | @Stanford Cancer Institute
Big hire for @Stanford
Congratulations @VivekSubbiah !!!! med.stanford.edu/cancer/about/n…
English
Pauline Funchain retweetledi
Stanford #Melanoma’s @FunchainMD leading us through a fantastic discussion of immune checkpoint toxicity #irAE in patients with pre-existing autoimmune disease. #CMC26 @StanfordCancer
English
Pauline Funchain retweetledi
Are you an APP with interest/experience in cell therapy and/or solid tumors? Our growing team
@StanfordCancer is hiring a Solid Tumor Cell Therapy APP! Please apply or send to anyone who you think would be a great candidate.
…nfordhealthcare.wd5.myworkdayjobs.com/SHC_External_C…
English
Good morning Vegas! 🎰 Shoutout to our pharmacy colleagues that keep us honest and keep our patients safe!
Thank you to @ASHPOfficial for featuring irAE care 💪 If you are a oncology pharmacist, join our pharmacy group @ASPIRE_CoP
English
Pauline Funchain retweetledi
Day 30 #NaGraWriMo: 15 (gra) ✅
Nov 2025 total: 557 mins writing 📝
Not 12 days of Christmas, but 30 days of Nov:
-5 pgs cut ✂️
-4 talks in 3 days 🎤
-2 manuscripts, 2 abstracts edited ✔️
-rainsoaked @scoutingamerica campout 🏕️
-@dodgers WS win💍
and
-1 aims page 📃
#grateful
Pauline Funchain@FunchainMD
Day 29 #NaGraWriMo: 25 (gra) ✅ Nov 2025 total: 542 mins writing 📝 Today's insight: Cut 0.5 pg! Down to 7.5... Now in the cuts that hurt 😅😂
English
Day 29 #NaGraWriMo: 25 (gra) ✅
Nov 2025 total: 542 mins writing 📝
Today's insight: Cut 0.5 pg! Down to 7.5... Now in the cuts that hurt 😅😂
Pauline Funchain@FunchainMD
Day 28 #NaGraWriMo: 25 (gra) ✅ Nov 2025 total: 517 mins writing 📝 Today's insight: Black Friday changed the schedule but not the commitment. Day shopping and night writing ftw 🏆
English
Pauline Funchain retweetledi
What’s true in #PancreaticCancer precursor lesions is also true in #ColorectalCancer precursor lesions. @cncurtis @SnyderShot @StanfordMed demonstrate polyclonal origin of adenomas in patients with FAP.
Cancer as a manifestation of convergent evolution!
nature.com/articles/s4158…
English
Day 28 #NaGraWriMo: 25 (gra) ✅
Nov 2025 total: 517 mins writing 📝
Today's insight: Black Friday changed the schedule but not the commitment. Day shopping and night writing ftw 🏆
Pauline Funchain@FunchainMD
Day 27 #NaGraWriMo: 27 (gra) ✅ Nov 2025 total: 492 mins writing 📝 Happy Thanksgiving! Grateful for the opportunity to write and represent @StanfordCancer 🦃 Also, totally unintentional numerology in writing 27 mins for the 27th day 🍀
English
Day 27 #NaGraWriMo: 27 (gra) ✅
Nov 2025 total: 492 mins writing 📝
Happy Thanksgiving! Grateful for the opportunity to write and represent @StanfordCancer 🦃
Also, totally unintentional numerology in writing 27 mins for the 27th day 🍀
Pauline Funchain@FunchainMD
Day 25 and 26 #NaGraWriMo: 10 (gra) and 15 (gra) ✅ Nov 2025 total: 465 mins writing 📝 Rounding the bases...3 more pages trimmed ✂️
English
Pauline Funchain retweetledi
Why do some patients respond better to immunotherapy? 🤔
nature.com/articles/s4158…
💥 @Nature: PPP2R1A mutations linked to improved outcomes with ICB! Across cancer types, PPP2R1A-mutant tumors show:
🎯 ↑ OS & PFS after ICB
🦠 ↑ IFN-γ signalling & T-cell infiltration
▪️ Preclinical data: targeting PP2A boosts ICB & CAR-T efficacy
If a scaffold protein becomes a signal…biology tells where therapy should go next!
@OncoAlert #OncoAlertAF @OncoReporte @myESMO @_SEOM
English
Hugely impactful work addressing the toughest of diagnoses - leptomeningeal disease. Early trial discontinuation due to significant benefit of proton craniospinal irradiation (pCSI). Kudos to the authors including @DrBetofMDPhD @StanfordCancer 🙏🧠
JAMA Oncology@JAMAOnc
Proton craniospinal irradiation significantly improves survival outcomes compared to involved-field radiotherapy for patients with leptomeningeal metastases from non–small cell lung cancer and breast cancer. ja.ma/4prVyJn
English
Pauline Funchain retweetledi
Our CMO @jrgralow joined @NPR to discuss the impact unstable federal funding for cancer research has on the U.S.’s ability to attract & retain talented researchers & physicians. Funding & other challenges threaten to accelerate “brain drain.” brnw.ch/21wXP1F #ASCOAdvocacy
English